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Membrane ﬂuidityCholesterol plays an important role in the interaction of Alzheimer’s amyloid beta (Ab) with cell
membranes, an important event in Ab-induced cytotoxicity. However, it is not fully understood
how cholesterol inﬂuences the association of Ab with membrane lateral compartments. We have
shown that by modulating membrane ﬂuidity, cholesterol decreased peptide localization in solid-
ordered domains and increased that in liquid-ordered domains. It changed the amount of Ab asso-
ciating with liquid-disordered (Ld) phase with different tendencies depending on the composition
of heterogeneous membrane systems. 7-Ketocholesterol, an oxidized derivative of cholesterol,
majorly enhanced the ﬂuidity of and Ab interaction with Ld phase. These ﬁndings are useful for
clarifying the impact of cholesterol and its oxidation in Ab-induced toxicity.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The aggregation and cytotoxicity of amyloid beta (Ab), a key
factor in Alzheimer’s disease (AD), are mediated by the interaction
of the peptide with cell membranes [1,2]. Accumulating evidences
have indicated that Ab is able to speciﬁcally bind to some mem-
brane components such as monosialotetrahexosylganglioside
(GM1) [3,4] or directly insert into membrane’s lipid bilayer [5,6].
This interaction triggers a cascade of harmful processes including
formation of ion-permeable amyloid pores [7], interference of
receptor activities [8], and oxidation of membrane lipids [9]. There-
fore, a clear understanding of the condition and mechanism of Ab/
membrane interaction is important to unravel Ab-induced cytotox-
icity during AD’s pathogenesis.
Cholesterol, an essential structural constituent and property
modulator of cell membranes [10], has been widely implicated in
Ab/membrane interaction [11,12]. However, it is not fully under-
stood how cholesterol affects the interaction of Abwith membranelateral compartments. An important membrane micro-domain, the
lipid raft, is enriched in sphingolipids and cholesterol [13]. Recent
studies have indicated that cholesterol speciﬁcally binds to Ab [14]
and accelerates the speciﬁc interaction between sphingolipid GM1
with the peptide [15–17], thus promoting the recruitment of Ab in
lipid rafts. In addition, some authors have suggested that the pep-
tide can selectively adsorb in or insert into lipid bilayer of mem-
brane lateral compartments depending on its aggregated states
and the structure of these compartments [18,19]. Since cholesterol
remarkably mediates the structure and properties of membrane
domains, the sterol can inﬂuence the association of Ab with the
lipid bilayer of these domains.
This study aims to investigate the effect of cholesterol and its
oxidized derivative, 7-Ketocholesterol (7keto), on the association
of protoﬁbrillar Ab-42, the reportedly highly neurotoxic amyloid
species [20,21], with heterogeneous membranes’ phases. 7keto is
the major product of cholesterol oxidation induced by reactive
oxygen species [22] and is shown to signiﬁcantly affect membrane
properties and interaction with Ab [23–25]. We employed a heter-
ogeneous cell-sized liposome system, composed of cholesterol,
equal concentrations of unsaturated phospholipid and saturated
phospholipid. This ternary model membrane tends to form a
liquid-disordered (Ld) phase coexisting with solid-ordered (So)
phase at low cholesterol fraction (0–10%) or liquid-ordered (Lo)
3484 H.T.T. Phan et al. / FEBS Letters 588 (2014) 3483–3490phase at higher cholesterol levels (10–45%) [26]. Ld and So are con-
sidered as liquid–crystalline and gel states of biological mem-
branes, respectively, whist Lo is lipid raft-like domains [27].
2. Materials and methods
2.1. Materials
1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dipalm-
itoyl-sn-glycero-3-phosphocholine (DPPC) and cholesterol (Chol)
were purchased from Avanti Polar Lipids (USA). Water-soluble cho-
lesterol, 7-ketocholesterol (7keto), methyl-b-cyclodexin (MbCD),
and bovine serum albumin (BSA) were obtained from Sigma–
Aldrich (USA). Amyloid beta protein (Human, 1-42) (Ab-42) and
Hilyte Fluor™ 488-labelled (kex = 503 nm, kex = 528 nm) Ab-42
were from Peptide Institute Inc. (Japan) and Anaspec, Inc. (USA),
respectively. Roswell Park Memorial Institute 1640 (RPMI1640)
medium, fetal bovine serum (FBS), Rhodamine b 1,2-dihexadeca-
noyl-sn-glycero-3-phosphoethanolamine triethylammonium salt
(Rho-DHPE) (kex = 560 nm, kem = 580 nm), Alexa Fluor 555 conju-
gated cholera toxin subunit B (CT-B) (kex = 555 nm, kem = 565 nm),
6-dodecanoyl-2-dimethylaminonaphthalene (Laurdan) (kex = 363 -
nm, kem = 497 nm) were from Invitrogen (USA). Jurkat human leu-
kemic T cell line (T cell) was from Riken cell bank (Japan). All other
reagents were of analytical grade.
2.2. Preparation of cell-sized heterogeneous liposomes
Cell-sized heterogeneous liposomes were prepared following
natural swelling method [28]. So/Ld liposomes were prepared with
two cholesterol concentrations, Chol 0% (DOPC/DPPC/Choles-
terol = 50/50/0 M ratio) and Chol 10% (DOPC/DPPC/Choles-
terol = 45/45/10 M ratio). Similarly, two Lo/Ld liposome systems
were prepared, including Chol 20% (DOPC/DPPC/Cholesterol = 40/
40/20 M ratio) and Chol 30% (DOPC/DPPC/Cholesterol = 35/35/
30 M ratio). Higher cholesterol levels were not used because of dif-
ﬁculty in preparation of stable Lo/Ld cell-sized vesicles. In order to
study the effect of 7keto, we used Chol 30% Lo/Ld liposomes
because this cholesterol concentration is closer to that in cell mem-
branes [10]. Cholesterol was replaced with 7keto at Chol/7keto
(75/25) ratio. To visualize membrane lateral compartments,
0.05% (mol/mol) Rho-DHPE, a speciﬁc probe of DOPC, was
added into lipid mixtures. The ﬁnal lipid concentration was
0.1 mM.
2.3. Cell culture and visualization of lipid rafts
T cells were cultured in RPMI1640 medium supplemented with
10% (v/v) FBS. They were maintained in a humidiﬁed atmosphere
with 5% (v/v) CO2 at 37 C. Lipid rafts were labelled by treating cells
with 15 lg/ml CT-B [29] and 0.02% (v/v) BSA solution at 0 C for
30 min, followed by an incubation at 37 C for 10 min.
2.4. Preparation of protoﬁbrillar Ab
We prepared 200 lM Ab-42 solutions by dissolving Ab-42 pow-
der in 0.02% (v/v) ammonia. Fluorescence-labelled Ab and Ab was
mixed and diluted in Tris buffer (20 mM, pH 7.4) at 80 lM concen-
tration, subsequently incubated at 37 C for 12 h [18,25]. Ab-42
conformation was measured by atomic force microscopic measure-
ment (SPA400-SPI 3800, Seiko Instruments Inc., Japan), analysed
using SpiceI32 and Image J. Fig. S2 shows that assembled species
were largely protoﬁbrillar with an average height of 3.18 nm and
lengths in the range from 50 to 250 nm [30].2.5. Modulation of membrane cholesterol and 7keto level
Membrane cholesterol of T cells was depleted by treating cells
with 2 mMMbCD in non-serum RPMI1640 medium for 10 min at
37 C [31]. In order to increase cholesterol content, cells were trea-
ted with 1 mM soluble cholesterol for 10 min at 37 C. Membrane
cholesterol level was measured using cholesterol cell-base detec-
tion assay kit (Cayman, USA) and presented in Fig. S3. 7keto was
added to cell membranes by treating cells with 7keto solution at
two concentrations (5 lM and 10 lM) for 10 min at 37 C.
2.6. Observation of Ab localization in model heterogeneous
membranes and T cells
Fluorescence-labelled Ab was added to liposome or T cell sus-
pension at 5 lM ﬁnal concentration. The resultant mixture was
poured into a silicon well (0.1 mm) placed on a glass slide and used
for confocal microscopy observation (Olympus FV-1000, Japan) at
room temperature (21.5 C) within 2 min. This observation per-
iod is short enough to avoid effect of ﬂuorescent quenching [25].
Membrane lateral compartments and Ab localization were visual-
ized after excitation of Rho-DHPE or CT-B and ﬂuorescence-
labelled Ab, respectively.
2.7. Measurement of membrane ﬂuidity
Fluidity of membrane lateral compartments was measured
using excitation generalized polarization (GP) of Laurdan [32]. Lip-
osomes were labeled with 0.2% (mol/mol) Laurdan. Fluorescent
emission of Laurdan was detected at 421 and 519 nm using confo-
cal scanning microscopy. Laurdan GP value was calculated follow-
ing the formula GP ¼ ðI421 þ I519Þ=ðI421 þ I519Þ, in which I421 and I519
are average ﬂuorescent intensities of Laurdan detected at 421 and
519 nm, respectively [32].
3. Results and discussion
3.1. Cholesterol-modulated localization of Ab in membrane lateral
compartments
In So/Ld heterogeneous membranes without cholesterol, Ab
protoﬁbrils localized in both So and Ld phase (Fig. 1A). The selec-
tive localization of Ab in So domain as well as its random distribu-
tion in both So and Ld phases has been reported [18,19]. The
presence of cholesterol in the vesicles decreased the amount of
Ab protoﬁbrils partitioning in So domains, while that in Ld phase
was signiﬁcantly increased (Fig. 1A). This implies that the sterol
is able to inhibit the interaction of the peptide with So and facili-
tate its association with Ld domains.
Fig. 1B shows that in Lo/Ld membranes containing low concen-
tration of cholesterol (20%, mol/mol), Ab localized mainly in Ld
phase, in agreement with Morita et al. [18]. At a higher cholesterol
level (30%, mol/mol), Ab association in Ld phase was reduced. The
peptide was able to associate with Lo domains although its amount
was lower than that in Ld (Fig. 1B). This result in combination with
So/Ld membrane study shows that cholesterol is a modulator of
the interaction of protoﬁbrillar Ab with lipid bilayer of heteroge-
neous membranes. Brieﬂy, cholesterol enabled the protoﬁbrils to
interact with Lo (raft-like) domains at a moderate level. On the
other hand, loss of cholesterol strongly enhanced Ab localization
in So which can exist in lipid rafts of cell membranes deﬁcient in
the sterol. Cholesterol could increase or decrease Ab association
with Ld phase depending on the composition of heterogeneous
membranes.
Fig. 1. Effect of cholesterol on the localization of protoﬁbrillar amyloid beta (1-42) in heterogeneous model membranes. (A) Representative confocal microscopy images (i)
and ﬂuorescence intensity values (ii) reﬂecting the amount of Ab localizing in So/Ld phase-separated membranes. Red and black regions indicate Ld and So domains,
respectively. (B) Representative confocal microscopy images (i) and ﬂuorescence intensity values (ii) reﬂecting the amount of Ab associating with Lo/Ld phase-separated
membranes. Red and black regions indicate Ld and Lo domains, respectively. The values are mean ± S.E. of three replicates. The symbols ⁄, ⁄⁄, and ⁄⁄⁄ show signiﬁcant
differences with P 6 0.1, P 6 0.05, and P 6 0.01. Scale bars are 5 lm.
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systems, we further advanced our study and used T-cells. T cells
have been used as a model cell system in studies on organization
and functions of lipid rafts [33,34]. Accumulated evidences have
indicated the occurrence of Ab-reactive T cells in the brain of AD
mouse model and patients which play important roles in Ab-
induced inﬂammation [35–37]. We found that T cells with the
basal cholesterol content are able to associate with Ab. This associ-
ation was not signiﬁcantly changed when membrane cholesterol
level was increased (Fig. 2). Meanwhile, the partial loss of mem-
brane cholesterol strongly increased the peptide localization in
cells. The result was in a good agreement with previous studies
on neuronal cells, which showed that the interaction of amyloid
oligomers with membranes was increased by membrane choles-
terol depletion [12,38]. However, the protoﬁbrils majorly located
in cell membranes, not internalized into cells as observed in neuro-
nal cells. There were tangle-like yellow regions attaching to the
outside of membranes, representing the co-localization of Ab with
lipid raft’s constituents which might be partially expelled from
membranes (Fig. 2B). This suggests that Ab interacts with lipid
rafts and the interaction was modulated by cholesterol.3.2. The effect of 7keto on the localization of protoﬁbrillar Ab in
membrane lateral compartments
We previously reported the enhancing impact of 7keto on Ab
insertion into homogeneous model membranes [25]. Here, we
sought to assess whether the presence of 7keto in membranes
affects the ability of Ab protoﬁbrils to localize in heterogeneous
membrane’s phases. Fig. 3A demonstrates that the substitution of
cholesterol with 7keto signiﬁcantly increased Ab localization in
overall Lo/Ld membrane systems. The increase was inﬂuenced by
a higher recruitment of the protoﬁbrils to Ld phase of 7keto-con-
taining lipid vesicles relative to cholesterol-containing systems.
The interaction of Ab with Lo phase was not signiﬁcantly inﬂu-
enced by 7keto (Fig. 3A).
Effect of 7keto on Ab/T-cell-membrane interaction was subse-
quently investigated. 7keto was introduced to T cells at 5 and
10 lM concentrations which are nearly similar to the level
detected in rat hippocampus after kainite excitotoxicity (2500–
3100 ng/g tissue) [39]. Similar to heterogeneous lipid vesicles,
the introduction of 7keto to T cells strongly facilitated the protoﬁ-
brils to associate with membranes. In contrast, the cells which
Fig. 2. Effect of cholesterol on protoﬁbrillar amyloid beta (1-42) (Ab-42) association with Jurkat T cell membranes. (A) Representative confocal microscopy images showing
the localization of Ab-42 protoﬁbrils in cell membranes. (B) Fluorescence intensity values reﬂecting the amount of Ab-42 protoﬁbrils localizing in cell membranes. The values
are mean ± S.E. of three replicates. The symbol ⁄⁄ indicates signiﬁcant differences with P 6 0.05. Scale bars are 10 lm.
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changes in Ab localization compared to the control, suggesting that
the oxysterol had a higher ability to increase Ab/membrane inter-
action than cholesterol (Fig. 3B).
3.3. The effect of cholesterol and 7keto on the ﬂuidity of membrane
lateral compartments
Many studies have reported that the Ab/cell-surfaces interaction
strongly depends on the physicochemical properties of membranes
[40–42]. Therefore, to understand how cholesterol and 7keto inﬂu-
ence this interaction, we studied their effect on ﬂuidity of heteroge-
neous membranes using generalized polarization of Laurdan, a
common ﬂuorescent marker of membrane ﬂuidity [32,43].
As can be seen in Fig. 4, the presence of cholesterol in So/Ld lipid
vesicles decreased GP value of vesicles, representing an increase of
ﬂuidity. GP value of Ld phase was also reduced, suggesting that the
phase was more ﬂuid. Conversely, the So phase became more rigid
as indicated by a higher GP value compared to membranes without
cholesterol (Figs. 4A and S4A). The results appear to contradict pre-
vious ﬁndings of the cholesterol’s rigidifying effect on liquid phase
and ﬂuidifying effect on gel phase [44]. However, our results
agreed with Parassi and colleagues who demonstrated that adding
cholesterol renders gel phase more ordered. The authors also
pointed out that the So and Ld domains of the binary vesicles are
not simply pure gel and liquid phases [32]. In agreement, we pro-
posed that there were some DOPC molecules in gel phase as wellwas DPPC molecules in liquid phase of the binary vesicles. When
cholesterol was present in the vesicles, it may compete with DOPC
for interaction with DPPC due to the preferential biding of the ste-
rol with saturated lipids. Thereby, DOPC molecules were excluded
from So domains and a similar exclusion of DPPC from Ld domains
occurred. As a result, So domains mainly consisted of saturated
phospholipids and cholesterol, thus becoming more rigid. On the
other hand, Ld phase of cholesterol-containing lipid vesicles was
more ﬂuid without DPPC. In case of Lo/Ld systems, overall lipo-
somes and Ld phase had a higher GP value when cholesterol con-
centration increased, implying that they were more ordered. By
contrast, Lo phase became more dis-ordered upon cholesterol
increase, as demonstrated by a reduction of GP value (Figs. 4B
and S4B). This is consistent with previous report of cholesterol
impact on membrane ﬂuidity [44].
In 7keto-containing lipid vesicles, GP values of liposomes and
Ld phase were remarkably lower than the system without the oxy-
sterol, while that of Lo phase was not noticeably different (Figs. 5
and S4C). This indicates that 7keto mainly affected Ld phase, ren-
dering it more ﬂuid and the oxysterol did not inﬂuence the ﬂuidity
of Lo phase. The ability of 7keto to increase membrane ﬂuidity may
involve in its orientation in lipid bilayer which adopts a tilt with
respect to membrane surface so that both oxygen groups are
exposed to the hydrophilic interface, thus decreasing membrane
lipid packing [23].
Effect of cholesterol and 7keto on ﬂuidity of Lo/Ld membrane
systems was strikingly different. The former changed ﬂuidity of
Fig. 3. The effect of 7-Ketocholesterol on localization of protoﬁbrillar amyloid beta (1-42) (Ab-42) in membranes. (A) Representative confocal microscopy images (i) and
ﬂuorescence intensity values (ii) reﬂecting the amount of Ab in Lo/Ld phase-separated membranes. Red and black regions indicate Ld and Lo domains, respectively. (B)
Representative confocal microscopy images (i) and ﬂuorescence intensity of Ab localizing in Jurkat T cells. Fluorescence intensity values of treated T cells relative to untreated
cells, of which the value was deﬁned as 100% (ii). The values are mean ± S.E. of three replicates. The symbols ⁄⁄ and ⁄⁄⁄ show signiﬁcant differences with P 6 0.05 and P 6 0.01.
Scale bars are 5 lm (A) and 10 lm (B).
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Because cholesterol contains a small hydrophilic headgroup at
one end of the molecule combining with a rigid tetracyclic ring
and non-polar iso-octyl side chain at the other end, it adopts a per-
pendicular orientation with respect to the plane of lipid bilayers.
Although cholesterol preferentially binds to DPPC, the abundant
phospholipid species in Lo phase, this sterol is also able to interactwith DOPC in Ld phase. The orientation of cholesterol in both
phases is reported to be similar (Fig. S5). This orientation enables
cholesterol to weaken hydrophobic-driven interaction in DPPC-
enriched domains and enhance that in DOPC-rich phase, resulting
in a relatively more ﬂuid Lo phase and more densely packed Ld
phase [45]. Conversely, the orientation of 7keto in Lo phase and
Ld phases may be different. The driving force determining the
Fig. 4. Effect of cholesterol on the ﬂuidity of heterogeneous model membranes. (A)
Laurdan generalized polarization (GP) values of So/Ld phase-separated membranes
(B) GP values of Lo/Ld phase-separated membranes. Laurdan shows emission
maximum at 490 nm in a polar environment and at 440 nm in non-polar one.
Environment polarity was determined by the number of water molecules existing
in the lipid bilayers which depends on lipid packing and membrane ﬂuidity.
Laurdan GP was calculated by comparing ﬂuorescent intensity at the two
wavelengths is able to give information about membrane properties. A more ﬂuid
environment has a lower GP value compared to a less ﬂuid environment. The values
are mean ± S.E. of three replicates. The symbols ⁄, ⁄⁄, and ⁄⁄⁄ indicate signiﬁcant
differences with P 6 0.1, P 6 0.05, P 6 0.01.
Fig. 5. Effect of 7-Ketocholesterol on the ﬂuidity of heterogeneous model mem-
branes. The values are mean ± S.E. of three replicates. The symbols ⁄⁄ and ⁄⁄⁄ show
signiﬁcant differences with P 6 0.05 and P 6 0.01, respectively.
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der Waals attractive interaction between the oxysterol and
hydrocarbon chain of phospholipids. Therefore, 7keto orientsTable 1
Correlation of amyloid beta (1-42) protoﬁbrils localization in heterogeneous membrane p
Membrane systems Phases Low cholesterol H
Fluidity Ab-42 localization F
So/Ld So Low High D
Ld High Low In
Lo/Ld Lo Low Low In
Ld High High Dquasi-perpendicular like cholesterol and the substitution of choles-
terol with 7keto does not signiﬁcantly change the ﬂuidity of Lo
phase. Nevertheless, the driving force of 7keto orientation in Ld
phase is hydrogen bonding of the carbonyl group with surface
polar groups of DOPC. Therefore, the oxysterol produces a marked
tilt with respect to the surface, leading to a decreased lipid packing
and an increased ﬂuidity of this phase [45]. Moreover, 7keto has a
stronger tendency to partition into Ld phase compared to choles-
terol [45], which is attributed to a signiﬁcant effect of 7keto on this
phase.
3.4. Cholesterol and 7keto modulate Ab localization in heterogeneous
membranes by changing membrane ﬂuidity
Microscopic observation and Laurdan GP study suggested that
cholesterol and 7keto may inﬂuence the localization of Ab protoﬁ-
brils in heterogeneous membranes through their effect on mem-
brane ﬂuidity (Table 1). Previous studies showed that the peptide
adsorbs to the surface of rigid gel phase [18,19]. However, the
adsorption is not detected at a high membrane surface pressure
(above 30 mNm1) [41]. Our results show that addition of choles-
terol induced a higher rigidiﬁcation of So phase (Fig. 4A), correlat-
ing with an increase of compressed state and surface pressure of
the phase which in turn inhibited Ab adsorption (Fig. 1A). Con-
versely, the peptides interact with Lo/Ld system via a direct inser-
tion into the liquid phase [18,46]. The insertion is mainly driven by
hydrophobic interaction between the linear and highly lipophilic
region containing residues 25–35 of Ab with hydrophobic part of
membrane lipids [6,18]. Scala and colleagues reported that this
interaction is speciﬁc for cholesterol and the peptide [13]. D’Errico
et al. also reported that the peptide is able to interact with hydro-
carbon chain of phospholipids [6]. In our study, we have indicated
that there is interaction between Ab and cholesterol-containing
membranes as well as oxidized cholesterol-containing mem-
branes. Varying the concentration of cholesterol and the presence
of cholesterol oxidized derivative (7keto) do have an effect on
how and where (which phase) Ab interacts with the membrane.
Our work has also shown that cholesterol and 7keto do alter mem-
brane ﬂuidity, and we have attributed the degree of Ab interaction
with membrane systems, largely to the changes in ﬂuidity. The
degree of Ab insertion into the membrane is dependent on the ﬂu-
idity of the bilayer. A similar conclusion on the impact of ﬂuidity
was reported previously [6,40]. Membrane ﬂuidity inﬂuences area
expansion modulus which is proportional to the energy needed for
the formation of a vacant space in the lipid bilayer interior for Ab
insertion [18,47]. According to our experimental data, the higher
cholesterol levels made Lo phase more ﬂuid (Fig. 4B), thereby pro-
moting the protoﬁbrils to penetrate into this phase (Fig. 1B). An
opposite effect of the sterol was observed in Ld phase. The partial
substitution of cholesterol with 7keto signiﬁcantly increased the
ﬂuidity of Ld phase (Fig. 5), resulting in a higher amount of Ab asso-
ciating with this phase (Fig. 3A).
In conclusion, we have demonstrated that cholesterol affected
the localization of protoﬁbrillar Ab-42 in all membrane lateral
compartments by modulating membrane ﬂuidity. A decrease in
basal cholesterol level increased Ab-42 association with T cellhases and membrane ﬂuidity upon the effect of cholesterol and 7-Ketocholesterol.
igh cholesterol Presence of 7keto
luidity Ab-42 localization Fluidity Ab-42 localization
ecreasing Decreasing  
creasing Decreasing  
creasing Increasing No change No change
ecreasing Decreasing Increasing Increasing
H.T.T. Phan et al. / FEBS Letters 588 (2014) 3483–3490 3489membranes. We have shown that the presence of 7keto hugely
enhanced the protoﬁbrils to partition into Ld phase because of
7keto’s ability to induce a signiﬁcant increase in ﬂuidity of this
phase. Moreover, the enhancing effect of 7keto on Ab-42/T-cell
interaction was also observed. Our ﬁndings suggest that a moder-
ate level of cholesterol is important in maintaining the membrane
ﬂuidity which prevents the recruitment of high levels of Ab in
membranes, while cholesterol oxidation appears to be a risk factor
in Ab-induced cytotoxicity.Acknowledgements
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